Clinical Trial Update: Evaluation of Efficacy and Safety of Highly Purified Urofollitropin in Chinese Females Undergoing an Assisted Reproductive Technology (ART) Program [Phase 3]

View source ↗

Summary

Phase 3 trial update evaluating the efficacy and safety of highly purified urofollitropin in Chinese women undergoing assisted reproductive technology has compl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Infertility

Drugs mentioned

• Bravelle (urofollitropin)

Snippet

Sponsor: Ferring Pharmaceuticals | Conditions: Infertility | Phase 3 | Status: COMPLETED